The Impact of comorbidities and obesity on the severity of COVID-19 and risk factors for mortality: a prospective study in hospitalized patients
Main Article Content
Abstract
Background- The studies of the clinical and demographic characteristics of COVID-19 patients around the world have made it possible to observe a rich semiology, which implicated obesity as a factor in the severity of COVID-19 pneumonia, and can lead to intensive care or even death. Some biomarkers have been identified as risk factors for mortality. The aim of this study was to verify obesity and the risk factors for mortality of COVID-19 infection.
Methods- This was a single-center prospective study carried out at Rouiba University Hospital, between March 19, 2020 to September 30, 2021. The clinical data were collec-ted: age (year), BMI groups (? 30 and <30 kg / m2), sex, active smoking, medical history, clinical complaints, peripheral oxygen saturation (SpO2) at admission, and the length of hospital stay. A standard laboratory assessment and a chest CT without a contrast agent were performed. The prognostic was verified, and the healing, death, or transfers to intensive care were noted, and the data was analyzed.
Résultats-Our results showed an obesity rate (26.8%) and a mortality rate (5.3%) and found that obesity increases the risk of severity but not mortality in hospitalized pa-tients. The risk factors for death from COVID-19 were the underlying chronic diseases in-cluding diabetes, COPD, renal failure and cardiovascular disease, hypoxia on admission,
elevated serum LDH, CRP, and D-Dimer levels.
Conclusion-The inclusion of obesity and risk factors in therapeutic management strate- gies and prognostic scores will be essential to improve the prognosis of hospitalized CO-VID-19 patients.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
A- Open Access statement and license:
1-Open Access statement:
JFMO provides immediate open access to published content in support of the idea that free access to research helps support the dissemination of knowledge and ideas in the field of medical science. All articles will be published under Creative Commons licenses.
All published data is immediate free access to the work and permits any user to read, download, copy, distribute print, search, or link to the full texts of articles.
The users of any published material in the JFMO must act in accordance with the Creative Commons Licenses CC BY-NC-ND 4.0.
2-License:
All published data is distributed following the Creative Commons Licenses CC BY-NC-ND 4.0. This license is allowing others to download the works and share them with others as long as they correctly cite the manuscript, No changes are allowed to the original manuscript and the manuscript must be used only for non for profit or non-commercial purposes.
This work is licensed under a Creative Commons AttributionNonCommercial-NoDerivatives 4.0 International License.
3-Self Archiving:
Authors are permitted and encouraged to share online their articles published in JFMO (e.g., in institutional repositories or on their website), as it can lead to productive exchanges, as well as earlier and greater citation of published work.
